Treatment and survival outcomes of lobular carcinoma in situ of the breast: a SEER population based study

Lobular carcinoma in situ (LCIS) represents 5.3% of in situ specimens, and is thought to carry a low risk for developing to the invasive lobular breast cancer (ILC). There is still no standard care approach for patients with LCIS. We aimed to define the impacts of surgical and radiation intervention...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Pu, Huang, Qi, Shou, Jiafeng, Hu, Guoming, Han, Mengjiao, Huang, Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5732709/
https://www.ncbi.nlm.nih.gov/pubmed/29262543
http://dx.doi.org/10.18632/oncotarget.21461

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5732709/
https://www.ncbi.nlm.nih.gov/pubmed/29262543
http://dx.doi.org/10.18632/oncotarget.21461

Ejemplares similares